Jade Biosciences JBIO Current ratio

Current ratio at other companies

Vertex PharmaceuticalsVRTX

3.2×+0.7×

Climb Global Solutions, Inc.CLMB

1.1×+0.1×

Travere Therapeutics, Inc.TVTX

3.1×+1.1×

Vera TherapeuticsVERA

13.6×-14.0×

Vor BiopharmaVOR

31.1×+27.3×

AnaptysBio, Inc.ANAB

7.6×-0.7×

FAQ

What is Jade Biosciences's current ratio?

Jade Biosciences (JBIO) reported current ratio of 14.3× in Q1 2026.

How has Jade Biosciences's current ratio changed year-over-year?

Jade Biosciences's current ratio decreased by 55.4% year-over-year, from 32× to 14.3×.

What is the long-term trend for Jade Biosciences's current ratio?

Over 5 years (2020 to 2025), Jade Biosciences's current ratio has grown at a 51.6% compound annual growth rate (CAGR), from 2.6× to 21.1×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.